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is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular
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subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD
biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis
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RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these
mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several
oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration.
These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human
AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms
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Introduction
Age-related macular degeneration (AMD) is the leading cause of  blindness among people over 50 years 
of  age in the industrialized world (1). Early disease is characterized by cholesterol-rich extracellular 
deposits underneath the retinal pigment epithelium (RPE) called drusen (2–4) or in the subretinal space 
called subretinal drusenoid deposits (SDD) (5–7). The composition of  these deposits is similar to that 
of  atherosclerotic plaques (3). AMD shares several phenotypic characteristics with atherosclerosis, 
including monocytic inflammation, pathologic angiogenesis, and genetic abnormalities in cholester-
ol homeostasis (4, 8). Although the molecular mechanisms underlying pathological angiogenesis or 
RPE atrophy in advanced disease are better understood, there is a paucity of  animal models that have 
been able to recapitulate early human disease — including anatomic features such as thickening of  
Bruch’s membrane (BrM; an acellular lamina underneath the RPE), drusen, or SDD — or functional 
characteristics such as an association with age, rod photoreceptor dysfunction (9, 10), or impaired dark 
adaptation (11, 12).
Advanced age-related macular degeneration (AMD), the leading cause of blindness among people 
over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis. 
Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal 
pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid 
deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis 
remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol 
homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic 
immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that 
targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads 
to age-associated extracellular cholesterol-rich deposits underneath the neurosensory retina 
similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a 
cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision 
is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant 
accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing 
lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings 
suggest that impaired macrophage cholesterol transport initiates several key elements of early 
human AMD, demonstrating the importance of systemic immunity and aging in promoting disease 
manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis 
are associated with a significantly higher risk of developing AMD, thus making these studies 
translationally relevant by identifying potential targets for therapy.
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A number of  genome-wide association studies (GWAS) have linked AMD to polymorphisms in genes 
involved in many facets of  cholesterol homeostasis such as LIPC, ApoE, ABCA1, and CETP (13, 14). In 
addition, widespread systemic disturbances in cholesterol metabolism as manifested by altered levels of  
lipoprotein subtypes have also been associated with AMD (15). Despite reports implicating disruptions in 
cholesterol homeostasis in mouse models and in human AMD pathogenesis, it has not been established 
whether it is the systemic immune system or local “eye” cells that regulate cholesterol clearance and the 
development of  the early AMD phenotype. Here, we demonstrate that, in conditional KO mice wherein 
both Abca1 and Abcg1 are deleted in macrophages, there is an age-dependent manifestation of  several ana-
tomic and functional AMD disease phenotypes, indicating that cholesterol clearance by macrophages plays 
a critical role in the early stages of  AMD pathogenesis.
Numerous studies have demonstrated that cellular and humoral components of  the innate immune 
system including macrophages, mononuclear phagocytes, and complement proteins contribute to both the 
development and severity of  AMD (16–19). Macrophages not only function as antigen-presenting cells and 
phagocytic sensors of  danger, but they are also important in cholesterol regulation by removing choles-
terol from peripheral tissues and transporting it back to the liver through the bloodstream. This process is 
termed cholesterol efflux or reverse cholesterol transport (RCT) (3), and ABCA1 and ABCG1 play crucial 
roles in macrophage RCT by effluxing cholesterol from cells to extracellular carriers such as ApoA1 and 
HDL, respectively (20). In this study, we generated conditional KO mice wherein both Abca1 and Abcg1 are 
deleted in macrophages. We evaluated the retinas structurally by biomicroscopy, histology, and electron 
microscopy (EM) at 3–12 months of  age. In addition, we evaluated retinal function by electrophysiology.
Results
Deletion of  Abca1 and Abcg1 in macrophages does not affect the retina at 3 months of  age. We have previously report-
ed that mice selectively deficient in Abca1 in macrophages (Abca1fl/fl LysM-Cre–positive [Abca1–m/–m]) demon-
strated increased laser-injury induced choroidal neovascularization (CNV), one of  the characteristics of  
advanced AMD (17). However, when we analyzed treatment-naive Abca1–m/–m mice retinas up to 24 months 
of  age, we did not detect any functional abnormalities (Supplemental Figure 1, A–F; supplemental mate-
rial available online with this article; https://doi.org/10.1172/jci.insight.120824DS1) or biomicroscopic 
defects (Supplemental Figure 1G) compared with littermate controls (Abca1fl/fl Cre–negative; Abca1F/F) mice. 
Because Abca1–m/–m mice macrophages demonstrated significantly increased Abcg1 expression (Supplemental 
Figure 1H), we suspected that ABCG1 might compensate for ABCA1, as both ABCA1 and ABCG1 play 
crucial roles in macrophage RCT by effluxing cholesterol to extracellular carriers (20). For this reason, and 
to directly test whether macrophage cholesterol transport regulates the early AMD phenotype, we generated 
conditional KO mice wherein both Abca1 and Abcg1 are deleted in macrophages by crossing Abca1fl/fl and Abc-
g1fl/fl mice with LysM-Cre mice (17, 21). The deletion of  both genes in macrophages of  Abca1fl/fl and Abcg1fl/fl 
LysM-Cre positive (Abca1/g1–m/–m) mice was confirmed by quantitative PCR (qPCR) (Supplemental Figure 
2A). We also confirmed that these mice did not carry the Crb1 gene rd8 mutation (22) (data not shown). EM 
at 3 months of  age demonstrated large lipid droplets in Abca1/g1–m/–m macrophages but not in macrophages 
of  littermate control (Abca1fl/fl and Abcg1fl/fl Cre negative; Abca1/g1F/F) mice (Supplemental Figure 2B), consis-
tent with decreased cholesterol efflux in Abca1/g1–m/–m macrophages and confirming findings from previous 
studies (17, 23). However, functional analysis at 3 months of  age demonstrated that both scotopic and phot-
opic retinal responses (Figure 1, A–C) and dark adaptation curves recorded from Abca1/g1–m/–m mice retinas 
were normal (Figure 1D). In addition, in vivo imaging and histological examination of  retinal sections of  
Abca1/g1–m/–m mice did not show any substantial differences (Figure 1, E and F). These results suggest that 
deletion of  both ABCA1 and ABCG1 in macrophages does not affect retinal function, vision, or morpholo-
gy acutely or at a young age.
Abca1/g1–m/–m mice demonstrate RPE abnormalities, BrM thickening, and impaired dark adaptation at 6 months of  age. 
In order to simulate the human condition, we aged Abca1/g1–m/–m mice and their littermate controls. Upon anal-
ysis at 6 months age, we found that scotopic a-waveforms were now slightly attenuated in Abca1/g1–m/–m retinas 
compared with littermate controls, confirming scotopic rod photoreceptor dysfunction (Figure 2, A–C). In addi-
tion, 6-month-old Abca1/g1–m/–m eyes showed impaired dark adaptation (Figure 2D), consistent with the dysfunc-
tion of RPE cells. Notably, this combination of rod photoreceptor dysfunction and impaired dark adaptation is 
a key feature of early and intermediate AMD (9–12). Ultrastructural histology revealed disrupted RPE structure 
with accumulation of lipid globules in the eyes of Abca1/g1–m/–m mice but not in littermate controls (Figure 2E 
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and Supplemental Figure 3). Abca1/g1–m/–m mice RPE also showed increased BrM thickening (Figure 2, F and G), 
which is another morphological characteristic of human eyes with AMD.
Retinal neurodegeneration of  Abca1/g1–m/–m mice increases in severity and affects cone photoreceptors at 12 months of  
age. We next examined whether further aging would recapitulate additional features of human AMD in the 
mouse eye. At 12 months of age, both scotopic a- and b-waveforms were significantly attenuated in Abca1/g1–m/–m 
retinas compared with littermate controls (Figure 3, A and B), confirming additional rod neurodegeneration. In 
addition, photopic responses were also significantly attenuated (Figure 3C), suggesting cone photoreceptor dys-
function. Dark adaptation was also further impaired (Figure 3D). Biomicroscopic examination of Abca1/g1–m–/m 
eyes now showed yellowish white lesions scattered throughout the retina (Figure 3E).
Subretinal deposits of  Abca1/g1–m/–m mice progressively increase in number with age. The yellowish white 
lesions throughout the retina corresponded to hyperreflective outer retinal focal deposits underneath the 
neurosensory retina on optical coherence tomography (OCT) imaging (Figure 4A). Quantitative analysis 
of  these SD in Abca1/g1–m–/m mice showed progressive increase with age, with a significant number of  SD 
Figure 1. Three-month-old Abca1/g1–m/–m retinas do not show functional deficits or morphological abnormalities in the retina and RPE. (A–C) Elect-
roretinography (ERG) of 3-month-old Abca1/g1F/F (n = 5) and Abca1/g1–m/–m mice (n = 6). (A) Scotopic a-wave amplitude. (B) Scotopic b-wave ampli-
tude. (C) Photopic b-wave amplitude. No significant difference was detected by 2-way ANOVA. (D) Dark adaptation curves of 3-month-old Abca1/g1F/F 
(n = 5) and Abca1/g1–m/–m mice (n = 4). No significant difference was detected by 2-way ANOVA. (E) Representative fundus images of 3-month-old 
Abca1/g1F/F and Abca1/g1–m/–m mice. (F) Representative electron microscopy images of 3-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinal pig-
mented epithelium (RPE). Scale bar: 1 μm. Values are mean ± SEM.
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by 12 months of  age compared with littermate controls (Figure 4B). EM confirmed that the deposits were 
subretinal and contained lipid globules, degenerative vacuoles, and cellular debris (Figure 4C). Some SD 
were associated with infiltration of  mononuclear cells (Figure 4C).
Infiltrating cells in the subretinal space are Iba1- or F4/80-positive monocytic cells. To investigate the iden-
tity of  the cellular component of  SD, we performed IHC with a monocyte/microglial marker (Iba1), as 
well as qPCR of  the retina/RPE/choroid complex. The number of  Iba1-positive cells in the subretinal 
space, visualized by IHC, were significantly increased at 12 months of  age in Abca1/g1–m/–m mice (Fig-
ure 5, A and B). Increased Iba1 expression was also confirmed in the retina/RPE/choroid complex of 
Figure 2. Six-month-old Abca1/g1–m/–m retinas demonstrate decreased scotopic responses and impaired dark adaptation associated with disrupted RPE 
morphology and Bruch’s membrane thickening. (A–C) ERG of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 5). (A) Scotopic a-wave ampli-
tude. (B) Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. **P < 0.01 by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (D) 
Dark adaptation curves of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 8). *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way ANOVA with 
post hoc Bonferroni’s multiple comparison test. (E and F) Representative electron microscopy images of 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice 
retinal pigmented epithelium (RPE). (E) Illustration of dysmorphic changes in 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice RPE. Note the vacuoles 
(asterisks), photoreceptor disk fragments (yellow arrowhead), and lipid droplets (red arrowheads) in Abca1/g1–m/–m mice RPE. Scale bar: 1 μm. (F) Thickness 
change of 6-month-old Abca1/g1F/F (n = 6) and Abca1/g1–m/–m (n = 4) mice Bruch’s membrane (BrM). Note the white bars, which represent BrM thickness. 
Scale bar: 1 μm. (G) Quantification of BrM thickness. **P < 0.01 by 2-tailed unpaired t test. Values are mean ± SEM.
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Abca1/g1–m/–m mice by qPCR (Figure 5C). IHC with another monocyte/microglial marker (F4/80) also 
showed increased F4/80-positive cells in the subretinal space (Figure 5, D and E). Increased F4/80 
expression was also confirmed in the retina/RPE/choroid complex of Abca1/g1–m/–m mice by qPCR 
(Figure 5F). These results indicate that infiltrating cells in the subretinal space are likely macrophages/
microglia. Recent histological analysis of  human SDD describes the presence of  bloated macrophage 
clusters in these lesions (7). As such, SD of  old Abca1/g1–m/–m mice are phenotypically similar to SDD 
seen in human AMD.
Aged Abca1/g1–m/–m mice demonstrate lipid accumulation underneath the retina and within RPE. We further 
analyzed 12-month-old Abca1/g1–m/–m mice for the precise distribution of  lipid deposits and for specific 
composition. Oil Red O (ORO) staining demonstrated focal lipid accumulations within the RPE, as 
well as in the subretinal space (Figure 6A), consistent with the findings on EM ultrastructural analysis. 
Analysis of  the retina/RPE/choroid complex by liquid chromatography–tandem mass spectrometry 
(LC-MS/MS) revealed increased free cholesterol and several cholesterol metabolites (3β,5α,6β-choles-
tanetriol [C-triol] and 4β-hydroxycholesterol [4β-HC]) (Figure 6B), as well as several cholesterol ester 
species (Figure 6C). These findings demonstrate that the SD and lipids within RPE are composed of  
cholesterol and cholesterol esters, as well as cholesterol oxidation products that suggest a highly oxida-
tive environment within the lipid deposits.
Figure 3. Neurodegeneration of aged Abca1/g1–m/–m (12-month-old) retinas increases in severity and extends to photopic dysfunction with significant 
subretinal deposits. (A–C) Electroretinography (ERG) of 12-month-old Abca1/g1F/F (n = 5) and Abca1/g1–m/–m mice (n = 5). (A) Scotopic a-wave amplitude. (B) 
Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way ANOVA with post hoc Bonferroni’s multiple 
comparison test. (D) Dark adaptation curves of 12-month-old Abca1/g1F/F (n = 8) and Abca1/g1–m/–m (n = 5). *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way 
ANOVA with post hoc Bonferroni’s multiple comparison test. (E) Representative fundus images of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice reti-
nas. Note the white yellowish dots of Abca1/g1–m/–m mice retinas.
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Discussion
Here, we have demonstrated that, in conditional KO mice wherein macrophage cholesterol efflux capaci-
ties are disabled (Abca1/g1–m/–m), there is an age-dependent manifestation of  several early and intermediate 
anatomic AMD disease phenotypes, including cellular and noncellular SD similar to SDD, increased BrM 
thickening, and accumulation of  free cholesterol, cholesterol metabolites, and cholesteryl esters. In addition, 
KO mice demonstrate several key features of  early functional degradation seen in human AMD, including 
impaired dark adaptation and rod photoreceptor dysfunction.
Although we generated macrophage-specific conditional KO mice by crossing Abca1fl/fl and Abcg1fl/fl 
mice with LysM-Cre mice, it has been established that LysM-Cre promotes significant deletion not only 
in macrophages, but also in neutrophils (24). A previous study demonstrated variable deletion of  Abca1 
and Abcg1 in neutrophils (25). Thus, we cannot exclude the possibility that the deletion of  Abca1 and Abcg1 
in neutrophils might also affect the retinal phenotype. However, in addition to the fact that macrophages, 
but not neutrophils, play crucial roles in RCT from tissues, we demonstrated increased gene expression 
of  macrophage markers Iba1 and F4/80, but not the neutrophil marker Gr-1, in the eyes of  12-month-old 
Abca1/g1–m/–m mice (Supplemental Figure 4). For these reasons, we conclude that the retinal phenotypes 
we observed at 12 months of  age are mainly associated with dysfunctional Abca1- and Abcg1-deficient 
macrophages, although further study might elucidate this more precisely.
Figure 4. Subretinal deposits contain lipid globules and degenerative vacuoles. (A) Representative optical coherence tomography (OCT) imag-
es of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Note the subretinal hyperreflective deposits in Abca1/g1–m/–m mice retinas (red 
arrow) corresponding to fundus yellowish white dots. POS, photoreceptor outer segment. (B) Quantification of subretinal deposits in 3-, 6-, and 
12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Abca1/g1F/F, n = 10, 10, and 15; Abca1/g1–m/–m, n = 13, 24, and 16, respectively. ***P < 0.001 
by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (C) Representative electron microscopy images of 12-month-old Abca1/g1F/F 
and Abca1/g1–m/–m mice retinas. Note the vacuoles (asterisk) and lipid globules (red arrowheads) within the subretinal deposit in Abca1/g1–m/–m mice 
retinas. Scale bar: 1 μm. Values are mean ± SEM.
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Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with 
a significantly higher risk of  developing AMD (13, 14), thus making these studies translationally rel-
evant by identifying potential targets for therapy. Although there are no previous reports of  ABCG1 
polymorphisms associated with increased AMD risk, we found that, in Abca1–m/–m mice, ABCG1 might 
compensate for the lack of  ABCA1. As such, we wanted to effectively neutralize the efflux pathway by 
the deletion of  both Abca1 and Abcg1 in order to examine its effect on the retinal phenotype with aging.
We are also aware that ABCA1 polymorphisms associated with AMD risk are HDL elevating (26–30). 
HDL carrier capacity is not just limited by level but by the size and quality of  the particles available at 
the retinal choroidal interphase. In addition, these findings also suggest that there is a complex interplay 
between systemic lipid profiles and local lipid profiles in AMD.
Although we are proposing our mouse model as an early-stage AMD model, an important feature of AMD 
that is lacking in this model is the development of sub-RPE drusen and may represent metabolic differences 
between the mouse and human retina and RPE. However, although our mouse model (Abca1/g1–m/–m mice) does 
not demonstrate all the features of human disease, age is a key variable here, just as in human AMD that only 
affects people over the age of 50 years. Thus, these findings suggest that maintenance of cholesterol homeostasis 
and macrophage-mediated cholesterol efflux may be critical pathways that initiate the development of AMD. 
These pathways deserve further investigation in order to determine whether pharmacotherapeutic interventions 
targeting these pathways, either locally or systemically, might prove efficacious in either preventing the develop-
ment of early AMD or the progression to advanced stages of disease where vision loss is imminent.
Figure 5. Infiltrated cells in subretinal space are IBA1 and F4/80 positive. (A) Representative Iba1 IHC staining of 12-month-old Abca1/g1F/F and 
Abca1/g1–m/–m mice retinas. Red, Iba1; blue, DAPI. Scale bar: 50 μm. INL, inner nuclear layer; ONL, outer nuclear layer; POS, photoreceptor outer seg-
ment. (B) Quantification of Iba1-positive cells in subretinal space. Abca1/g1F/F, n = 5; Abca1/g1–m/–m, n = 5. **P < 0.01 by 2-tailed Mann-Whitney U test. 
(C) qPCR quantification of Iba1 expressions in the retina/RPE/choroid complex. Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 7. ***P < 0.001 and by 2-tailed 
unpaired t test. (D) Representative IHC staining of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Red, F4/80; blue, DAPI. Scale bar: 50 μm. 
(E) Quantification of F4/80-positive cells in the subretinal space. Abca1/g1
F/F
, n = 5; Abca1/g1–m/–m, n = 5. **P < 0.01 and by 2-tailed Mann-Whitney 
test. (F) qPCR quantification of F4/80 expressions in the retina/RPE/choroid complex. Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 7. ***P < 0.001 and by 
2-tailed unpaired t test. Values are mean ± SEM.
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Methods
Supplemental Methods are available online with this article.
Animals. All mice were housed in a temperature-controlled room under a 12-hour light/dark cycle, with free 
access to food and water. Abca1fl/fl and Abcg1fl/fl (Abca1/g F/F) mice were previously characterized (23) and were 
purchased commercially (The Jackson Laboratory). To generate mice lacking both Abca1 and Abcg1 specifically 
from macrophages, we crossed Abca1/g1F/F mice with mice carrying 1 copy of the LysM-Cre transgene, which 
were purchased commercially (The Jackson Laboratory) and have been previously characterized (17, 21, 23).
RNA isolation and qPCR. Total RNA was extracted using RNeasy Micro Plus kit (Qiagen) according to 
the manufacturer’s instructions. To synthesize cDNA, total RNA was added to the High Capacity cDNA 
Reverse Transcription Kit (Thermo Fisher Scientific) and reverse-transcribed according to manufacturer’s 
Figure 6. Lipid analysis of Abca1/g1–m/–m mice eyes at 12 months of age demonstrates focal subretinal and RPE deposits with increased cholesterol 
metabolites. (A) Representative Oil Red O staining of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Note the lipid deposits within the 
RPE (yellow arrowheads) or subretinal space (red arrowhead). Scale bar: 20μm. (B) Analyses of free cholesterol, 3β,5α,6β-cholestanetriol (C-triol), 
4β-hydroxycholesterol (4β-HC), 24-hydroxycholesterol (24-HC), 25-HC, 27-HC, and 7-ketocholesterol in retina/RPE/choroid complex at 12 months of 
age (normalized peak area ratio/mg wet tissue weight). Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 6. *P < 0.05 and **P < 0.01 by 2-tailed unpaired t test. (C) 
Analyses of cholesterol esters (CE) in retina/RPE/choroid complex at 12 months of age (normalized peak area ratio/mg wet tissue weight). Abca1/g1F/F, 
n = 7; Abca1/g1–m/–m, n = 6. **P < 0.01 and ***P < 0.001 by 2-tailed unpaired t test. Values are mean ± SEM.
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instructions. qPCR was performed in duplicate using the StepOnePlus Real Time PCR system (Thermo 
Fisher Scientific) using TaqMan Real-Time PCR Assays (Thermo Fisher Scientific), and the mRNA was 
quantified using the ΔΔCT method with gapdh or bactin as the internal control.
Transmission EM. We performed transmission EM as previously described (31). Briefly, for ultrastruc-
tural analyses, samples were fixed in 2% paraformaldehyde (PFA)/2.5% glutaraldehyde (Polysciences Inc.) 
in 100 mM sodium cacodylate buffer, pH 7.2, for 2 hours at room temperature and then overnight at 
4°C. Samples were washed in sodium cacodylate buffer at room temperature and postfixed in 1% osmium 
tetroxide (Polysciences Inc.) for 1 hour. Samples were then rinsed extensively in dH20 prior to en bloc stain-
ing with 1% aqueous uranyl acetate (Ted Pella Inc.) for 1 hour. Following several rinses in dH2O, samples 
were dehydrated in a graded series of  ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). Sections 
of  95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc.), stained with ura-
nyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA 
Inc.) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software 
(Advanced Microscopy Techniques).
To measure BrM thickness, we used 25,000× EM pictures. We set 5 measurement points that were 
arranged at equal 500-nm intervals and measured BrM thickness using Adobe Photoshop CS 5.1 (Adobe). 
We took averages of  each picture as representative BrM thickness.
Electroretinography (ERG). ERG was performed as previously described (32). Briefly, A UTAS BigShot 
System (LKC Technologies Inc.) was used. Mice were dark adapted overnight. Under red light illumi-
nation, mice were anesthetized with an i.p. injection of  86.9 mg/kg ketamine and 13.4 mg/kg xylazine. 
Pupils were dilated with 1% atropine sulfate eye drops (Bausch & Lomb). Body temperature was main-
tained at 37°C with a heating pad. Contact lens electrodes were placed bilaterally with appropriate refer-
ence and ground electrodes. The stimulus consisted of  a full-field white light flash (10 μs) in darkness or in 
the presence of  dim (30.0 candela [cd]/m2) background illumination after 10-minute adaptation time. Raw 
data were processed using MATLAB software (MathWorks). The amplitude of  the a-wave was measured 
from the average pretrial baseline to the most negative point of  the average trace, and the b-wave amplitude 
was measured from that point to the highest positive point.
For testing dark adaptation, we modified the protocol as previously described (33). Briefly, we used 
a UTAS BigShot System (LKC Technologies Inc.) to get scotopic a-waves. A bright LED light (150,000 
lux) was applied to both eyes for 15 seconds to photobleach an estimated 90% of  the visual pigment. The 
recovery of  the ERG responses was monitored at fixed post-bleach time points within 100 minutes after the 
bleach. The sensitivity was calculated as the ratio of  dim flash response amplitude and the corresponding 
flash intensity in the linear range of  the intensity-response curve. The post-bleach sensitivities were normal-
ized to their dark-adapted prebleach level.
Retinal imaging. We performed digital color fundus photography and OCT as previously described (21) 
using the Micron III animal fundus camera equipped with 830 nm OCT (Phoenix Research Labs). Prior 
to fundus imaging and OCT, we anesthetized mice with an i.p. injection of  86.9 mg/kg ketamine and 13.4 
mg/kg xylazine and administered 1.0% tropicamide eye drops (Bausch & Lomb) to dilate the pupils.
Cryopreservation. Enucleated posterior poles were fixed in 4% PFA followed by cryopreservation in 
Tissue-Tek OCT compound (Sakura Finetek). Cryosections (10-μm thick) were cut and collected on gela-
tin-coated slides and stored at –20°C until use. 
ORO staining. ORO (0.7%, MilliporeSigma) staining solution was prepared in 100% propylene glycol 
(MilliporeSigma) by heating the solution to 90°C. The staining protocol was as follows. Slides were rinsed 
with water and placed in 100% propylene glycol for 5 minutes, followed by staining overnight in preheated 
(60°C) ORO solution. Slides were next differentiated in 85% propylene glycol for 1 minute at room tem-
perature, followed by 2 rinses in water. Slides were dried at room temperature, mounted in Aqua-Poly/
Mount (Polysciences Inc.), and imaged using a ZEISS Axionplan 2 light microscope.
IHC. Retinal cryosections were incubated with a blocking solution of  10% normal goat serum 
(NGS) in PBTA (PBS, 0.5% BSA, 0.1% Triton, 0.05% Sodium Azide) for 2 hours at room temperature. 
After the blocking, sections were probed with either anti-Iba1 (Wako, catalog 019-19741; 1:200 in 
10% NGS-PBTA) or anti-F4/80 antibodies (Bio-Rad, catalog MCA497GA; 1:500 in 10% NGS-PBTA) 
overnight at 4 °C. The next day, anti-Iba1 sections were incubated in goat anti–rabbit-568 (Thermo 
Fisher Scientific, catalog A11011; 1:200 in 5% NGS-PBTA) and anti-F4/80 sections were incubated 
in goat anti–rat-568 (Thermo Fisher Scientific, catalog A11077; 1:200 in 5% NGS-PBTA), both for 
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2 hours at room temperature. Nuclei were counterstained with DAPI (MilliporeSigma). All sections 
were examined under a confocal microscope equipped with a digital camera (C2si confocal micro-
scope, Nikon Corporation). To count Iba1- or F4/80-positive cells in the subretinal space, 3 slides per 
animal were stained with Iba1 and F4/80, and 3 equidistant fields of  view were identified in the nasal, 
central, and temporal regions, per slide. The number of  staining positive cells were counted in each 
field of  view and their mean was taken (n). The n values from 3 slide were averaged as cell counts/field 
in the subretinal space.
Analyses of  oxysterols, free cholesterol, and cholesterol esters in retina/RPE/choroid complex. Each retina/
RPE/choroid complex was homogenized with 50-fold excess volume of  PBS buffer using Omni Bead 
Ruptor 24 (Omni International Inc.). All analytes listed above in 50 μl of  the mouse retina homogenate 
were extracted with 200 μl of  methanol. Prior to the extraction, triol-d7 (2 ng), 7-ketocholesterol-d7 (2 
ng), 24-hydroxycholesterol-d7 (24-HC-d7; 2 ng), 27-HC-d5 (2 ng), 4β-HC-d7 (2 ng), cholesterol esters 
(18:2)-d7 (CE[18:2]-d7;200 ng), and cholesterol-d7 (1 μg) were added as the internal standards to the 
homogenate samples. All oxysterols and cholesterol, as well as their deuterated standards, were deri-
vatized with N,N-dimethylglycine (DMG) to increase the MS sensitivity. Cholesterol esters were not 
derivatized for the MS analyses.
Oxysterol analysis was performed with a Shimadzu 20AD HPLC system and a Shimadzu SIL 20AC 
autosampler coupled to a triple quadrupole mass spectrometer (API-6500Qtrap+, Thermo Fisher Scientif-
ic) operated in multiple reaction monitoring (MRM) mode. The positive ion electrospray ionization (ESI) 
mode was used for detection of  the DMG derivatized oxysterols. All samples were injected in duplicate for 
data averaging. Data processing was conducted with Analyst 1.6.3 (Thermo Fisher Scientific).
The analysis of  free cholesterol and 2 CEs (CE[16:0] and CE[18:0]) was performed with a Shimadzu 
20AD HPLC system: a LeapPAL autosampler coupled to a triple quadrupole mass spectrometer (API 
4000) operated with positive ion MRM mode. The data processing was conducted with Analyst 1.5.1 
(Thermo Fisher Scientific).
The analysis of  the rest of  the CEs (CE[16:2], CE[18:1], CE[18:2], and CE[20:4]) was performed with 
a Shimadzu 10AD HPLC system and a Shimadzu SIL 20AC autosampler coupled to a triple quadrupole 
mass spectrometer (TSQ Quantum Ultra) operated in MRM mode. The data processing was conducted 
with XCalibur.
The relative quantification data is reported as peak area ratios of  analytes to their internal standards 
normalized to wet weights (mg) of  retina/RPE/choroid complex.
Statistics. We performed statistical testing with GraphPad Prism (Version 6.0), using the appropriate 
test for each dataset (2-way ANOVA, 2-way ANOVA with post hoc Bonferroni’s multiple comparison test, 
2-tailed unpaired t test, or 2-tailed Mann-Whitney U test). We defined statistical significance as a P < 0.05. 
Values are mean ± SEM.
Study approval. All animal experiments were reviewed and approved by the IACUC of  Washington 
University in St. Louis and performed in accordance with the Washington University School of  Medicine 
Animal Care and Use guidelines.
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